Related Experiment Video

Updated: Aug 15, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Undefined-antigen vaccines

Hong-Ming Hu1, Yiwei Chu, Walter J Urba

  • 1Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA.

Cancer Treatment and Research
|October 11, 2005
PubMed

Insights

Cancer vaccines combining immunotherapy advances with cellular antigens show promise. While not yet standard, these approaches are well-tolerated and demonstrate immunologic activity, suggesting potential for future effective cancer treatments.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Growing understanding of immune system-tumor cell interactions fuels novel cancer treatment strategies.
  • Recent decades have seen numerous advances in basic science applicable to cancer therapy.

Purpose of the Study:

  • To review strategies combining recent scientific advances with cellular antigen preparations for cancer vaccine development.
  • To assess the efficacy and tolerability of these experimental cancer vaccine approaches.

Main Methods:

  • Review of various strategies integrating new scientific knowledge with undefined cellular antigen preparations.
  • Analysis of clinical data regarding patient tolerance, immunologic activity, and clinical outcomes.

Main Results:

  • No reviewed cancer vaccine strategies have achieved standard therapy status.
  • Tested approaches were generally well-tolerated in patients with advanced cancer.
  • Evidence of significant immunologic activity and clinical responses across diverse malignancies was observed.

Conclusions:

  • Current experimental cancer vaccines, despite limitations, show encouraging safety and biological activity.
  • These strategies serve as foundational elements for developing more effective future cancer treatments.
  • Further research and integration of new advances hold potential for successful cancer vaccine development.

More Related Videos

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...